Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative analgesia and spinal block duration following total hip arthroplasties
2025-522358-38-02Phase 4Authorised
- Sponsor
- Turku University Hospital
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hip osteoarthritis and postoperative pain comparing Intrathecal bupivacaine with Intrathecal ropivacaine (2 arms). Primary endpoint: Return of sensory and motor function. Planned start Oct 2025; status: authorised.
02
Drugs
bupivacaineropivacaine
03
Conditions
hip osteoarthritispostoperative pain
Beyond the preview
Go deeper on 2025-522358-38-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522358-38-02.